The facility is expected to produce 500 million vaccine doses annually
Kenya has signed a deal with US biotechnology company, Moderna Inc, to build a vaccine manufacturing facility in the country.
The facility if expected to produce up to 500 million doses of vaccines annually.
The deal has been hailed as one that will help solve vaccine access in the current coronavirus pandemic and in future pandemics.
Moderna anticipates to invest more than $500m (£380m) in the facility.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
We thank God for the 2024 general elections – Akufo-Addo
13 minutes -
Coconut Grove Beach Resort marks 30 years of excellence with memorable 9 lessons & carols service
25 minutes -
WAFU B U-17 Girls’ Cup: Black Maidens beat Nigeria on penalties to win inaugral tournament
1 hour -
Real Madrid beat Sevilla to keep pressure on leaders Atletico
2 hours -
Liverpool put six past Spurs to go four points clear
2 hours -
Manchester United lose 3-0 at home to Bournemouth yet again
2 hours -
CHAN 2024Q: ‘It’s still an open game’ – Didi on Ghana’s draw with Nigeria
2 hours -
CHAN 2024Q: Ghana’s Black Galaxies held by Nigeria in first-leg tie
3 hours -
Dr Nduom hopeful defunct GN bank will be restored under Mahama administration
4 hours -
Bridget Bonnie celebrates NDC Victory, champions hope for women and youth
4 hours -
Shamima Muslim urges youth to lead Ghana’s renewal at 18Plus4NDC anniversary
5 hours -
Akufo-Addo condemns post-election violence, blames NDC
5 hours -
DAMC, Free Food Company, to distribute 10,000 packs of food to street kids
7 hours -
Kwame Boafo Akuffo: Court ruling on re-collation flawed
7 hours -
Samuel Yaw Adusei: The strategist behind NDC’s electoral security in Ashanti region
7 hours